520 related articles for article (PubMed ID: 31230975)
1. Histopathologic upgrading of nonmelanoma skin cancer at the time of Mohs micrographic surgery: A prospective review.
Kyllo RL; Staser KW; Rosman I; Council ML; Hurst EA
J Am Acad Dermatol; 2019 Aug; 81(2):541-547. PubMed ID: 31230975
[TBL] [Abstract][Full Text] [Related]
2. Clinical value of paraffin sections in association with Mohs micrographic surgery for nonmelanoma skin cancers.
Ebede TL; Lee EH; Dusza SW; Busam KJ; Nehal KS
Dermatol Surg; 2012 Oct; 38(10):1631-8. PubMed ID: 22958072
[TBL] [Abstract][Full Text] [Related]
3. Mohs appropriate use criteria: retrospectively applied to nonmelanoma skin cancers at a single academic center.
Chong T; Tristani-Firouzi P; Bowen GM; Hadley ML; Duffy KL
Dermatol Surg; 2015 Aug; 41(8):889-95. PubMed ID: 26066619
[TBL] [Abstract][Full Text] [Related]
4. Correlation Between Incisional Biopsy Histological Subtype and a Mohs Surgery Specimen for Nonmelanoma Skin Cancer.
Cortés-Peralta EC; Ocampo-Candiani J; Vázquez-Martínez OT; Gutiérrez-Villarreal IM; Miranda-Maldonado I; Garza-Rodríguez V
Actas Dermosifiliogr (Engl Ed); 2018; 109(1):47-51. PubMed ID: 29066323
[TBL] [Abstract][Full Text] [Related]
5. Correlation Between Original Biopsy Pathology and Mohs Intraoperative Pathology.
Stiegel E; Lam C; Schowalter M; Somani AK; Lucas J; Poblete-Lopez C
Dermatol Surg; 2018 Feb; 44(2):193-197. PubMed ID: 28857942
[TBL] [Abstract][Full Text] [Related]
6. Curettage prior to Mohs' micrographic surgery for previously biopsied nonmelanoma skin cancers: what are we curetting? Retrospective, prospective, and comparative study.
Jih MH; Friedman PM; Goldberg LH; Kimyai-Asadi A
Dermatol Surg; 2005 Jan; 31(1):10-5. PubMed ID: 15720088
[TBL] [Abstract][Full Text] [Related]
7. Laboratory errors leading to nonmelanoma skin cancer recurrence after Mohs micrographic surgery.
Zabielinski M; Leithauser L; Godsey T; Gloster HM
Dermatol Surg; 2015 Aug; 41(8):913-6. PubMed ID: 26218725
[TBL] [Abstract][Full Text] [Related]
8. Mohs micrographic surgery: a cost analysis.
Cook J; Zitelli JA
J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):698-703. PubMed ID: 9810885
[TBL] [Abstract][Full Text] [Related]
9. Risk of synchronous and metachronous second nonmelanoma skin cancer when referred for Mohs micrographic surgery.
Schinstine M; Goldman GD
J Am Acad Dermatol; 2001 Mar; 44(3):497-9. PubMed ID: 11209121
[TBL] [Abstract][Full Text] [Related]
10. Innovative 19-minute rapid cytokeratin immunostaining of nonmelanoma skin cancer in Mohs micrographic surgery.
Cherpelis BS; Turner L; Ladd S; Glass LF; Fenske NA
Dermatol Surg; 2009 Jul; 35(7):1050-6. PubMed ID: 19469800
[TBL] [Abstract][Full Text] [Related]
11. Mohs micrographic surgery concordance between Mohs surgeons and dermatopathologists.
Semkova K; Mallipeddi R; Robson A; Palamaras I
Dermatol Surg; 2013 Nov; 39(11):1648-52. PubMed ID: 24581313
[TBL] [Abstract][Full Text] [Related]
12. Nonmelanoma skin cancers of the ear: correlation between subanatomic location and post-Mohs micrographic surgery defect size.
Duffy KL; McKenna JK; Hadley ML; Tristani-Firouzi P
Dermatol Surg; 2009 Jan; 35(1):30-3. PubMed ID: 19018813
[TBL] [Abstract][Full Text] [Related]
13. Association Between Mohs Surgery Wait Times and Surgical Defect Size in Patients With Squamous Cell or Basal Cell Carcinoma of the Skin.
Diehl J; Choi YM; Liang LJ; Chiu M
Dermatol Surg; 2015 Jul; 41(7):768-74. PubMed ID: 26050214
[TBL] [Abstract][Full Text] [Related]
14. Basal cell carcinoma histopathologic upgrading and Mohs micrographic surgery: a single institution, retrospective review.
Walocko F; Chelliah P; Kolitz E; Awerman J; Nijhawan RI; Srivastava D
Arch Dermatol Res; 2022 Sep; 314(7):705-707. PubMed ID: 33683445
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical techniques in Mohs micrographic surgery: their potential use in the detection of neoplastic cells masked by inflammation.
Jimenez FJ; Grichnik JM; Buchanan MD; Clark RE
J Am Acad Dermatol; 1995 Jan; 32(1):89-94. PubMed ID: 7529778
[TBL] [Abstract][Full Text] [Related]
16. Potential utility of adjunctive histopathologic evaluation of some tumors treated by Mohs micrographic surgery.
Weisberg NK; Becker DS
Dermatol Surg; 2000 Nov; 26(11):1052-6. PubMed ID: 11096394
[TBL] [Abstract][Full Text] [Related]
17. Using frozen section margin control technique to manage non-melanomatous skin lesions in high-risk sites.
Nizamoglu M; Douglas H; McArdle C; Mathew B; Vize C; Matteucci P
J Plast Reconstr Aesthet Surg; 2016 May; 69(5):657-62. PubMed ID: 26850755
[TBL] [Abstract][Full Text] [Related]
18. Histopathologic upgrading of cutaneous squamous cell carcinomas during Mohs micrographic surgery: A retrospective cohort study.
Chung E; Hoang S; McEvoy AM; Rosman IS; Hurst EA; Council ML
J Am Acad Dermatol; 2021 Oct; 85(4):923-930. PubMed ID: 33812956
[TBL] [Abstract][Full Text] [Related]
19. Correlation of Inflammation in Frozen Sections With Site of Nonmelanoma Skin Cancer.
Alam M; Khan M; Veledar E; Pongprutthipan M; Flores A; Dubina M; Nodzenski M; Yoo SS
JAMA Dermatol; 2016 Feb; 152(2):173-6. PubMed ID: 26579703
[TBL] [Abstract][Full Text] [Related]
20. Incidence of invasive squamous cell carcinomas in biopsy-proven squamous cell carcinomas in situ sent for Mohs micrographic surgery.
Chuang GS; Lu LK; Cummins DL; Wu H; Finn D; Rogers GS; Lee D
Dermatol Surg; 2012 Sep; 38(9):1456-60. PubMed ID: 22734860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
